Literature DB >> 2822222

Central nervous system metastases in epithelial ovarian carcinoma.

J Dauplat1, R K Nieberg, N F Hacker.   

Abstract

Five new cases of central nervous system (CNS) metastases from epithelial ovarian cancer are described. They are discovered among 255 patients treated at University of California, Los Angeles (UCLA) Medical Center, giving an incidence of CNS metastases of 1.96%. All five patients had intraparenchymal brain metastases. It seems likely that the incidence of CNS involvement is increasing in this disease, consonant with improvement of local tumor control and prolonged overall survival. The median duration from the diagnosis of ovarian cancer to the diagnosis of CNS metastases was 25 months (range, 10-126 months). Median survival after diagnosis was 1.3 months (range, 1-10 months). Therapeutic options are discussed, as are possible mechanisms for the occurrence of these metastases.

Entities:  

Mesh:

Year:  1987        PMID: 2822222     DOI: 10.1002/1097-0142(19871115)60:10<2559::aid-cncr2820601035>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study.

Authors:  L T Vlasveld; J H Beynen; W Boogerd; W W Ten Bokkel Huinink; S Rodenhuis
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases.

Authors:  Giancarlo D'Andrea; Raffaelino Roperto; Lavinia Dinia; Emanuela Caroli; Maurizio Salvati; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2004-11-19       Impact factor: 3.042

3.  Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome.

Authors:  Zvi R Cohen; Dima Suki; Jeffrey S Weinberg; Eric Marmor; Frederick F Lang; David M Gershenson; Raymond Sawaya
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

4.  Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.

Authors:  Laura M Divine; Nora T Kizer; Andrea R Hagemann; Meredith E Pittman; Ling Chen; Matthew A Powell; David G Mutch; Janet S Rader; Premal H Thaker
Journal:  Gynecol Oncol       Date:  2016-05-08       Impact factor: 5.482

5.  Brain metastases from ovarian carcinoma.

Authors:  Ettie Piura; Benjamin Piura
Journal:  ISRN Oncol       Date:  2011-12-01

6.  Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients.

Authors:  E A Lien; K Wester; P E Lønning; E Solheim; P M Ueland
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

7.  Central nervous system metastasis in epithelial ovarian carcinoma: a case report and literature review.

Authors:  Fereshteh Fakour; Hadi Hajizadeh Fallah; Sina Khajeh Jahromi; Parham Porteghali
Journal:  J Family Reprod Health       Date:  2015-03

8.  Gamma knife surgery for brain metastases from ovarian cancer.

Authors:  Akiyoshi Ogino; Tatsuo Hirai; Takao Fukushima; Toru Serizawa; Takao Watanabe; Atsuo Yoshino; Yoichi Katayama
Journal:  Acta Neurochir (Wien)       Date:  2012-05-16       Impact factor: 2.216

9.  Choroidal eye metastases from (recurrent) primary peritoneal carcinoma: case report and review of the literature.

Authors:  Nikolaos Thomakos; Khandra Galaal; Georgios Georgopoulos; Lakshmi Nagaraju; Dianne Hemming; Raj Naik
Journal:  Int Semin Surg Oncol       Date:  2009-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.